Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
| index_endocrine [2024/11/05 01:47] – removed - external edit (Unknown date) 127.0.0.1 | index_endocrine [2025/03/28 17:18] (current) – jkohts | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| + | ====== Endocrine drugs ====== | ||
| + | |||
| + | <WRAP column 30%> | ||
| + | * Thyroid disease | ||
| + | * Thyroid drugs | ||
| + | * Anti-thyroid drugs | ||
| + | </ | ||
| + | |||
| + | <WRAP column 30%> | ||
| + | * Diabetes mellitus | ||
| + | * Insulins | ||
| + | * Insulin secretagogues | ||
| + | * Sulfonylureas | ||
| + | * Gliclazide | ||
| + | * Hypoglycemics acting on liver/ | ||
| + | * [[biguanide_toxicity|Biguanides]] | ||
| + | * Metformin | ||
| + | * Thiazolidinediones (glitazones) | ||
| + | * Pioglitazone | ||
| + | * Alpha-glucosidase inhibitors | ||
| + | * Acarbose | ||
| + | * DPP-4 inhibitors (gliptins) | ||
| + | * GLP-1 agonists | ||
| + | * Semaglutide | ||
| + | * SGLT-2 inhibitors | ||
| + | </ | ||
| + | |||
| + | <WRAP column 30%> | ||
| + | * | ||
| + | </ | ||